Frantzi M - Search Results

1

Frantzi M, Latosinska A, Mokou M, Mischak H, Vlahou A. Frantzi M, et al. Lancet Oncol. 2020 Dec;21(12):e543. doi: 10.1016/S1470-2045(20)30610-0. Lancet Oncol. 2020. PMID: 33271100 No abstract available.

2

Profilin 1 is a potential biomarker for bladder cancer aggressiveness.

Zoidakis J, Makridakis M, Zerefos PG, Bitsika V, Esteban S, Frantzi M, Stravodimos K, Anagnou NP, Roubelakis MG, Sanchez-Carbayo M, Vlahou A. Zoidakis J, et al. Among authors: frantzi m. Mol Cell Proteomics. 2012 Apr;11(4):M111.009449. doi: 10.1074/mcp.M111.009449. Epub 2011 Dec 8. Mol Cell Proteomics. 2012. PMID: 22159600 Free PMC article.

3

Proteomics approaches in the quest of kidney disease biomarkers.

Frantzi M, Bitsika V, Charonis A, Vlahou A. Frantzi M, et al. Prilozi. 2011;32(2):33-51. Prilozi. 2011. PMID: 22286613 Review.

4

Biomarkers for bladder cancer aggressiveness.

Frantzi M, Makridakis M, Vlahou A. Frantzi M, et al. Curr Opin Urol. 2012 Sep;22(5):390-6. doi: 10.1097/MOU.0b013e328356ad0e. Curr Opin Urol. 2012. PMID: 22825458 Review.

5

IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers.

Frantzi M, Zoidakis J, Papadopoulos T, Zürbig P, Katafigiotis I, Stravodimos K, Lazaris A, Giannopoulou I, Ploumidis A, Mischak H, Mullen W, Vlahou A. Frantzi M, et al. J Proteome Res. 2013 Sep 6;12(9):3969-79. doi: 10.1021/pr400255h. Epub 2013 Aug 21. J Proteome Res. 2013. PMID: 23924207

6

Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.

Latosinska A, Frantzi M, Vlahou A, Mischak H. Latosinska A, et al. Among authors: frantzi m. Proteomics Clin Appl. 2013 Dec;7(11-12):779-93. doi: 10.1002/prca.201300038. Proteomics Clin Appl. 2013. PMID: 23970371 Review.

7

Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.

Frantzi M, Metzger J, Banks RE, Husi H, Klein J, Dakna M, Mullen W, Cartledge JJ, Schanstra JP, Brand K, Kuczyk MA, Mischak H, Vlahou A, Theodorescu D, Merseburger AS. Frantzi M, et al. J Proteomics. 2014 Feb 26;98:44-58. doi: 10.1016/j.jprot.2013.12.010. Epub 2013 Dec 25. J Proteomics. 2014. PMID: 24374379 Clinical Trial.

8

Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.

Frantzi M, Bhat A, Latosinska A. Frantzi M, et al. Clin Transl Med. 2014 Mar 29;3(1):7. doi: 10.1186/2001-1326-3-7. Clin Transl Med. 2014. PMID: 24679154 Free PMC article.

9

Targeting the proteome of cellular fractions: focus on secreted proteins.

Latosinska A, Frantzi M, Mullen W, Vlahou A, Makridakis M. Latosinska A, et al. Among authors: frantzi m. Methods Mol Biol. 2015;1243:29-41. doi: 10.1007/978-1-4939-1872-0_2. Methods Mol Biol. 2015. PMID: 25384738

10

Developing proteomic biomarkers for bladder cancer: towards clinical application.

Frantzi M, Latosinska A, Flühe L, Hupe MC, Critselis E, Kramer MW, Merseburger AS, Mischak H, Vlahou A. Frantzi M, et al. Nat Rev Urol. 2015 Jun;12(6):317-30. doi: 10.1038/nrurol.2015.100. Epub 2015 May 26. Nat Rev Urol. 2015. PMID: 26032553 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page